Completed PHASE4 INTERVENTIONAL 2-arm NCT02181023

Acute Effect of Aclidinium on Hyperinflation and Ventilation Inhomogeneity in Severe COPD Patients

Acute Effect of Aclidinium on Hyperinflation and Lung Volume Distribution in Severe COPD Patients

Sponsor: Fondazione Salvatore Maugeri

Conditions Chronic Obstructive Pulmonary Disease

Interventions Aclidinium Bromide Glycopyrronium Bromide

Updated 5 times since 2017 Last updated: Oct 28, 2014 Started: Jun 30, 2014 Primary completion: Sep 30, 2014 Completion: Oct 31, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02181023, this PHASE4 trial focuses on Chronic Obstructive Pulmonary Disease and remains completed. Sponsored by Fondazione Salvatore Maugeri, it has been updated 5 times since 2014, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Jun 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Fondazione Salvatore Maugeri
University of Milan

Data source: University of Milan

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Milan, Italy